Related Experiment Videos
Mortality in concurrent type 1 diabetes and anorexia nervosa
Søren Nielsen1, Charlotte Emborg, Anne-Grethe Mølbak
1Departments of Child and Adolescent Psychiatry F, H:S Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark. sn04@bbh.hosp.dk
Diabetes Care
|January 30, 2002
Summary
Concurrent type 1 diabetes and anorexia nervosa (AN) in females leads to significantly higher mortality rates. This preliminary study highlights the urgent need for integrated treatment approaches for this vulnerable population.
Area of Science:
- Endocrinology
- Psychiatry
- Public Health
Background:
- Diabetic complications often manifest early, but excess mortality data is scarce.
- Previous studies have not adequately quantified mortality risks in patients with concurrent type 1 diabetes and anorexia nervosa (AN).
Purpose of the Study:
- To estimate and analyze mortality rates in females with concurrent type 1 diabetes and AN.
- To compare mortality risks between type 1 diabetes, AN, and concurrent cases.
Main Methods:
- Analysis of mortality using crude mortality rate, standardized mortality ratio (SMR), incidence rate ratio, risk difference, and survival analysis.
- Retrospective data analysis combining information from earlier studies.
Main Results:
- Concurrent type 1 diabetes and AN cases exhibited the highest mortality rate (34.6 per 1,000 person-years) and SMR (14.5).
- Both type 1 diabetes (SMR 4.06) and AN (SMR 8.86) alone showed increased mortality compared to the general population.
- Survival analysis confirmed significant between-group differences in mortality.
Conclusions:
- Concurrent type 1 diabetes and AN is a rare but critical condition associated with substantial excess mortality.
- Integrated and aggressive treatment strategies involving diabetologists and eating disorder specialists are crucial.
- Further research into subclinical eating disorders in diabetic populations is warranted.